| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC3803 |
| Trial ID | NCT06313957 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LUCAR-20SP |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LUCAR-20SP, an Allogenic Chimeric Antigen Receptor(CAR)-T Cell Therapy Targeting CD20 in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma |
| Year | 2024 |
| Country | China |
| Company sponsor | Peking University Cancer Hospital & Institute |
| Other ID(s) | LB2302-0001 |
| Cohort 1 | |||||||||
|
|||||||||